Exposure-Response Analyses of Datopotamab Deruxtecan (Dato-DXd), a TROP2-Directed Antibody-Drug Conjugate, in Advanced Non-small Cell Lung Cancer.

Datroway (datopotamab deruxtecan-dlnk) - Daiichi Sankyo, AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/42733211

Anna M Mc Laughlin; Diansong Zhou; Malaz AbuTarif; Michael Chargualaf; Naoyuki Tajima; Sofia Friberg Hietala; Sophie Peigné; Tushar Garimella; Ying Hong; Yuzhuo Pan; Zoey Tang

Sep 15, 2026